{"id":"https://openalex.org/W7225197487","doi":"https://doi.org/10.2147/opth.s606642","title":"Effectiveness and Safety Outcomes After Switching from Reference Biologics to Biosimilars for Treatment of Non-Infectious Uveitis: A Systematic Review and Meta-Analysis","display_name":"Effectiveness and Safety Outcomes After Switching from Reference Biologics to Biosimilars for Treatment of Non-Infectious Uveitis: A Systematic Review and Meta-Analysis","publication_year":2026,"publication_date":"2026-11-01","ids":{"openalex":"https://openalex.org/W7225197487","doi":"https://doi.org/10.2147/opth.s606642","pmid":"https://pubmed.ncbi.nlm.nih.gov/42999825","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/13744183"},"language":"en","primary_location":{"id":"doi:10.2147/opth.s606642","doi":"https://doi.org/10.2147/opth.s606642","is_oa":true,"landing_page_url":"https://doi.org/10.2147/opth.s606642","pdf_url":"https://www.dovepress.com/article/download/121787","source":{"id":"https://openalex.org/S105513329","display_name":"Clinical ophthalmology","issn_l":"1177-5467","issn":["1177-5467","1177-5483"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","doyens","jufo-1","ki-jl-1","norway-1","oarl","poland-100","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320348","host_organization_name":"Dove Medical Press","host_organization_lineage":["https://openalex.org/P4310320348","https://openalex.org/P4310320547"],"host_organization_lineage_names":["Dove Medical Press","Taylor & Francis"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Ophthalmology","raw_type":"journal-article"},"volume":null,"type":"review","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://www.dovepress.com/article/download/121787","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5073241581","display_name":"Tina Felfeli","orcid":"https://orcid.org/0000-0002-0927-3086","observed_orcids":["https://orcid.org/0000-0002-0927-3086"]},"institutions":[{"id":"https://openalex.org/I185261750","display_name":"University of Toronto","ror":"https://ror.org/03dbr7087","country_code":"CA","type":"education","lineage":["https://openalex.org/I185261750"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"Tina Felfeli","raw_affiliation_strings":["Department of Ophthalmology and Vision Sciences, University of Toronto, Toronto, ON, Canada","Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, ON, Canada"],"raw_orcid":"https://orcid.org/0000-0002-0927-3086","affiliations":[{"raw_affiliation_string":"Department of Ophthalmology and Vision Sciences, University of Toronto, Toronto, ON, Canada","institution_ids":["https://openalex.org/I185261750"]},{"raw_affiliation_string":"Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, ON, Canada","institution_ids":["https://openalex.org/I185261750"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5016769154","display_name":"MSc Natalie Kozlowski","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I185261750","display_name":"University of Toronto","ror":"https://ror.org/03dbr7087","country_code":"CA","type":"education","lineage":["https://openalex.org/I185261750"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"Natalie Kozlowski","raw_affiliation_strings":["Temerty Faculty of Medicine, University of Toronto, Toronto, ON, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Temerty Faculty of Medicine, University of Toronto, Toronto, ON, Canada","institution_ids":["https://openalex.org/I185261750"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5079468351","display_name":"Felicia Tai","orcid":"https://orcid.org/0000-0003-0652-6946","observed_orcids":["https://orcid.org/0000-0003-0652-6946"]},"institutions":[{"id":"https://openalex.org/I98251732","display_name":"McMaster University","ror":"https://ror.org/02fa3aq29","country_code":"CA","type":"education","lineage":["https://openalex.org/I98251732"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"Felicia Tai","raw_affiliation_strings":["Division of Ophthalmology, McMaster University, Hamilton, ON, Canada"],"raw_orcid":"https://orcid.org/0000-0003-0652-6946","affiliations":[{"raw_affiliation_string":"Division of Ophthalmology, McMaster University, Hamilton, ON, Canada","institution_ids":["https://openalex.org/I98251732"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108744414","display_name":"Jorge R. Georgakopoulos","orcid":"https://orcid.org/0000-0002-6844-2724","observed_orcids":["https://orcid.org/0000-0002-6844-2724"]},"institutions":[{"id":"https://openalex.org/I185261750","display_name":"University of Toronto","ror":"https://ror.org/03dbr7087","country_code":"CA","type":"education","lineage":["https://openalex.org/I185261750"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"Jorge R Georgakopoulos","raw_affiliation_strings":["Division of Dermatology, Department of Medicine, University of Toronto, Toronto, ON, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Dermatology, Department of Medicine, University of Toronto, Toronto, ON, Canada","institution_ids":["https://openalex.org/I185261750"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5140104569","display_name":"Jihad Waked","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I125749732","display_name":"Western University","ror":"https://ror.org/02grkyz14","country_code":"CA","type":"education","lineage":["https://openalex.org/I125749732"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"Jihad Waked","raw_affiliation_strings":["Schulich School of Medicine and Dentistry, Western University, London, ON, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Schulich School of Medicine and Dentistry, Western University, London, ON, Canada","institution_ids":["https://openalex.org/I125749732"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5067934851","display_name":"Sherif R. El-Defrawy","orcid":"https://orcid.org/0000-0002-7678-9947","observed_orcids":["https://orcid.org/0000-0002-7678-9947"]},"institutions":[{"id":"https://openalex.org/I185261750","display_name":"University of Toronto","ror":"https://ror.org/03dbr7087","country_code":"CA","type":"education","lineage":["https://openalex.org/I185261750"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"Sherif El-Defrawy","raw_affiliation_strings":["Department of Ophthalmology and Vision Sciences, University of Toronto, Toronto, ON, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Ophthalmology and Vision Sciences, University of Toronto, Toronto, ON, Canada","institution_ids":["https://openalex.org/I185261750"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5050289436","display_name":"Laura C. Rosella","orcid":"https://orcid.org/0000-0003-4867-869X","observed_orcids":["https://orcid.org/0000-0003-4867-869X"]},"institutions":[{"id":"https://openalex.org/I185261750","display_name":"University of Toronto","ror":"https://ror.org/03dbr7087","country_code":"CA","type":"education","lineage":["https://openalex.org/I185261750"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"Laura C Rosella","raw_affiliation_strings":["Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, ON, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, ON, Canada","institution_ids":["https://openalex.org/I185261750"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5001830614","display_name":"Jessica Widdifield","orcid":"https://orcid.org/0000-0002-7464-0460","observed_orcids":["https://orcid.org/0000-0002-7464-0460"]},"institutions":[{"id":"https://openalex.org/I185261750","display_name":"University of Toronto","ror":"https://ror.org/03dbr7087","country_code":"CA","type":"education","lineage":["https://openalex.org/I185261750"]},{"id":"https://openalex.org/I4210167439","display_name":"Sunnybrook Hospital","ror":"https://ror.org/008kn1a71","country_code":"CA","type":"healthcare","lineage":["https://openalex.org/I1323843004","https://openalex.org/I4210167439"]},{"id":"https://openalex.org/I4391768120","display_name":"Sunnybrook Research Institute","ror":"https://ror.org/05n0tzs53","country_code":"CA","type":"facility","lineage":["https://openalex.org/I1323843004","https://openalex.org/I185261750","https://openalex.org/I4391768120"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"Jessica Widdifield","raw_affiliation_strings":["HollandBone and Joint Research Program, Sunnybrook Research Institute, Toronto, ON, Canada","Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, ON, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"HollandBone and Joint Research Program, Sunnybrook Research Institute, Toronto, ON, Canada","institution_ids":["https://openalex.org/I4210167439","https://openalex.org/I4391768120"]},{"raw_affiliation_string":"Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, ON, Canada","institution_ids":["https://openalex.org/I185261750"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5059034061","display_name":"Rafael Neves Miranda","orcid":"https://orcid.org/0000-0003-2173-0021","observed_orcids":["https://orcid.org/0000-0003-2173-0021"]},"institutions":[{"id":"https://openalex.org/I185261750","display_name":"University of Toronto","ror":"https://ror.org/03dbr7087","country_code":"CA","type":"education","lineage":["https://openalex.org/I185261750"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"Rafael N Miranda","raw_affiliation_strings":["Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, ON, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, ON, Canada","institution_ids":["https://openalex.org/I185261750"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":5,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":2320,"currency":"USD","value_usd":2320},"apc_paid":{"value":2320,"currency":"USD","value_usd":2320},"fwci":0.0,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":{"value":0.66491951,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"Volume 20","issue":null,"first_page":"1","last_page":"18"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11194","display_name":"Ocular Diseases and Beh\u00e7et\u2019s Syndrome","score":0.9639000296592712,"subfield":{"id":"https://openalex.org/subfields/2731","display_name":"Ophthalmology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11194","display_name":"Ocular Diseases and Beh\u00e7et\u2019s Syndrome","score":0.9639000296592712,"subfield":{"id":"https://openalex.org/subfields/2731","display_name":"Ophthalmology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12255","display_name":"Biosimilars and Bioanalytical Methods","score":0.030799999833106995,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10134","display_name":"Inflammatory Bowel Disease","score":0.0005000000237487257,"subfield":{"id":"https://openalex.org/subfields/2715","display_name":"Gastroenterology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/biosimilar-switching","display_name":"biosimilar switching","score":0.6539999842643738},{"id":"https://openalex.org/keywords/non-infectious-uveitis","display_name":"non-infectious uveitis","score":0.8399999737739563},{"id":"https://openalex.org/keywords/adalimumab","display_name":"adalimumab","score":0.8640000224113464},{"id":"https://openalex.org/keywords/uveitis-recurrence","display_name":"uveitis recurrence","score":0.8059999942779541},{"id":"https://openalex.org/keywords/visual-acuity","display_name":"visual acuity","score":0.8429999947547913},{"id":"https://openalex.org/keywords/adverse-events","display_name":"adverse events","score":0.8610000014305115},{"id":"https://openalex.org/keywords/medication-discontinuation","display_name":"drug discontinuation","score":0.925000011920929},{"id":"https://openalex.org/keywords/risk-of-bias","display_name":"risk of bias","score":0.47999998927116394},{"id":"https://openalex.org/keywords/confounding","display_name":"confounding","score":0.6919999718666077},{"id":"https://openalex.org/keywords/anti-tnf-therapy","display_name":"anti-TNF therapy","score":0.4880000054836273},{"id":"https://openalex.org/keywords/biologic-switching","display_name":"biologic switching","score":0.34200000762939453},{"id":"https://openalex.org/keywords/drug-cost-reduction","display_name":"drug cost reduction","score":0.3709999918937683}],"concepts":[{"id":"https://openalex.org/C59491497","wikidata":"https://www.wikidata.org/wiki/Q864715","display_name":"Biosimilar","level":2,"score":0.9617999792098999},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.944599986076355},{"id":"https://openalex.org/C2778715236","wikidata":"https://www.wikidata.org/wiki/Q55622662","display_name":"Discontinuation","level":2,"score":0.8370000123977661},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.6668999791145325},{"id":"https://openalex.org/C82789193","wikidata":"https://www.wikidata.org/wiki/Q2142611","display_name":"Relative risk","level":3,"score":0.43959999084472656},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.4244999885559082},{"id":"https://openalex.org/C2779473830","wikidata":"https://www.wikidata.org/wiki/Q1540899","display_name":"MEDLINE","level":2,"score":0.40529999136924744},{"id":"https://openalex.org/C2780385302","wikidata":"https://www.wikidata.org/wiki/Q367158","display_name":"Protocol (science)","level":3,"score":0.40119999647140503},{"id":"https://openalex.org/C2780132546","wikidata":"https://www.wikidata.org/wiki/Q348260","display_name":"Adalimumab","level":3,"score":0.3935999870300293},{"id":"https://openalex.org/C2776478404","wikidata":"https://www.wikidata.org/wiki/Q1105187","display_name":"Cochrane Library","level":3,"score":0.376800000667572},{"id":"https://openalex.org/C3018989441","wikidata":"https://www.wikidata.org/wiki/Q691640","display_name":"Quality of evidence","level":3,"score":0.3472999930381775},{"id":"https://openalex.org/C3018359032","wikidata":"https://www.wikidata.org/wiki/Q1550789","display_name":"Safety profile","level":3,"score":0.3465000092983246},{"id":"https://openalex.org/C12174686","wikidata":"https://www.wikidata.org/wiki/Q1058438","display_name":"Risk assessment","level":2,"score":0.3409000039100647},{"id":"https://openalex.org/C57658597","wikidata":"https://www.wikidata.org/wiki/Q1550789","display_name":"Pharmacovigilance","level":3,"score":0.3343000113964081},{"id":"https://openalex.org/C2776194053","wikidata":"https://www.wikidata.org/wiki/Q280027","display_name":"Uveitis","level":2,"score":0.33230000734329224},{"id":"https://openalex.org/C189708586","wikidata":"https://www.wikidata.org/wiki/Q1504425","display_name":"Systematic review","level":3,"score":0.3321000039577484},{"id":"https://openalex.org/C167135981","wikidata":"https://www.wikidata.org/wiki/Q2146302","display_name":"Retrospective cohort study","level":2,"score":0.3312000036239624},{"id":"https://openalex.org/C2777802072","wikidata":"https://www.wikidata.org/wiki/Q413299","display_name":"Bevacizumab","level":3,"score":0.3116999864578247},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.29789999127388},{"id":"https://openalex.org/C2777596629","wikidata":"https://www.wikidata.org/wiki/Q10858520","display_name":"Inclusion and exclusion criteria","level":3,"score":0.28619998693466187},{"id":"https://openalex.org/C2777138892","wikidata":"https://www.wikidata.org/wiki/Q415264","display_name":"Infliximab","level":3,"score":0.2752000093460083},{"id":"https://openalex.org/C19648533","wikidata":"https://www.wikidata.org/wiki/Q691640","display_name":"Evidence-based medicine","level":3,"score":0.2736000120639801},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.2728999853134155},{"id":"https://openalex.org/C32896092","wikidata":"https://www.wikidata.org/wiki/Q189447","display_name":"Risk management","level":2,"score":0.26910001039505005},{"id":"https://openalex.org/C2779668873","wikidata":"https://www.wikidata.org/wiki/Q6693756","display_name":"Lower risk","level":3,"score":0.2651999890804291},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.2612999975681305},{"id":"https://openalex.org/C109359841","wikidata":"https://www.wikidata.org/wiki/Q728944","display_name":"Inclusion (mineral)","level":2,"score":0.257099986076355},{"id":"https://openalex.org/C194828623","wikidata":"https://www.wikidata.org/wiki/Q2861470","display_name":"Emergency medicine","level":1,"score":0.2529999911785126},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.2515999972820282}],"mesh":[],"locations_count":4,"locations":[{"id":"doi:10.2147/opth.s606642","doi":"https://doi.org/10.2147/opth.s606642","is_oa":true,"landing_page_url":"https://doi.org/10.2147/opth.s606642","pdf_url":"https://www.dovepress.com/article/download/121787","source":{"id":"https://openalex.org/S105513329","display_name":"Clinical ophthalmology","issn_l":"1177-5467","issn":["1177-5467","1177-5483"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","doyens","jufo-1","ki-jl-1","norway-1","oarl","poland-100","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320348","host_organization_name":"Dove Medical Press","host_organization_lineage":["https://openalex.org/P4310320348","https://openalex.org/P4310320547"],"host_organization_lineage_names":["Dove Medical Press","Taylor & Francis"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Ophthalmology","raw_type":"journal-article"},{"id":"pmid:42999825","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/42999825","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical ophthalmology (Auckland, N.Z.)","raw_type":"Journal Article"},{"id":"pmh:oai:doaj.org/article:5c57f2fa7f434f58a1586db3f1063057","doi":null,"is_oa":false,"landing_page_url":"https://doaj.org/article/5c57f2fa7f434f58a1586db3f1063057","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"Clinical Ophthalmology, Vol Volume 20, Iss Issue 1, Pp 1-18 (2026)","raw_type":"article"},{"id":"pmh:oai:dovepress.com/121787","doi":null,"is_oa":true,"landing_page_url":"https://www.dovepress.com/effectiveness-and-safety-outcomes-after-switching-from-reference-biolo-peer-reviewed-fulltext-article-OPTH","pdf_url":null,"source":{"id":"https://openalex.org/S4306401012","display_name":"Dove Medical Press (Taylor and Francis Group)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"Review"}],"best_oa_location":{"id":"doi:10.2147/opth.s606642","doi":"https://doi.org/10.2147/opth.s606642","is_oa":true,"landing_page_url":"https://doi.org/10.2147/opth.s606642","pdf_url":"https://www.dovepress.com/article/download/121787","source":{"id":"https://openalex.org/S105513329","display_name":"Clinical ophthalmology","issn_l":"1177-5467","issn":["1177-5467","1177-5483"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","doyens","jufo-1","ki-jl-1","norway-1","oarl","poland-100","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320348","host_organization_name":"Dove Medical Press","host_organization_lineage":["https://openalex.org/P4310320348","https://openalex.org/P4310320547"],"host_organization_lineage_names":["Dove Medical Press","Taylor & Francis"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Ophthalmology","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.98580002784729,"display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/systematic-review","display_name":"Systematic Review"},{"id":"https://openalex.org/study-designs/meta-analysis","display_name":"Meta-Analysis"}],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W7225197487.pdf","grobid_xml":"https://content.openalex.org/works/W7225197487.grobid-xml"},"referenced_works_count":61,"referenced_works":["https://openalex.org/W304295703","https://openalex.org/W1538992920","https://openalex.org/W1701993624","https://openalex.org/W1755785609","https://openalex.org/W1973288761","https://openalex.org/W1981336058","https://openalex.org/W1984733295","https://openalex.org/W1988128449","https://openalex.org/W1994307831","https://openalex.org/W2012240762","https://openalex.org/W2023048488","https://openalex.org/W2026629764","https://openalex.org/W2039104184","https://openalex.org/W2039919901","https://openalex.org/W2069010656","https://openalex.org/W2091721895","https://openalex.org/W2098398245","https://openalex.org/W2119138901","https://openalex.org/W2119740605","https://openalex.org/W2126930838","https://openalex.org/W2156098321","https://openalex.org/W2179942617","https://openalex.org/W2341182564","https://openalex.org/W2527393952","https://openalex.org/W2531269403","https://openalex.org/W2764082441","https://openalex.org/W2765631588","https://openalex.org/W2766388803","https://openalex.org/W2782470740","https://openalex.org/W2786897800","https://openalex.org/W2797296870","https://openalex.org/W2885257932","https://openalex.org/W2898444405","https://openalex.org/W2935510237","https://openalex.org/W2949092235","https://openalex.org/W2953850901","https://openalex.org/W2969256165","https://openalex.org/W2979322754","https://openalex.org/W2985097727","https://openalex.org/W2985705185","https://openalex.org/W2985947116","https://openalex.org/W3022365662","https://openalex.org/W3042481399","https://openalex.org/W3048797834","https://openalex.org/W3093730414","https://openalex.org/W3094869231","https://openalex.org/W3112289067","https://openalex.org/W3125261197","https://openalex.org/W3129999421","https://openalex.org/W3138509490","https://openalex.org/W3140698213","https://openalex.org/W3159189320","https://openalex.org/W3184598655","https://openalex.org/W3198275052","https://openalex.org/W3205912463","https://openalex.org/W4288009904","https://openalex.org/W4295752121","https://openalex.org/W4321436773","https://openalex.org/W4385829506","https://openalex.org/W4390706917","https://openalex.org/W4416416599"],"related_works":["https://openalex.org/W7139023793","https://openalex.org/W4416416599","https://openalex.org/W4283700927","https://openalex.org/W2985947116","https://openalex.org/W4390739662","https://openalex.org/W7214985560","https://openalex.org/W3093730414","https://openalex.org/W4412351358","https://openalex.org/W3138509490","https://openalex.org/W7213331704"],"abstract_inverted_index":{"Purpose:":[0],"This":[1],"study":[2],"aims":[3],"to":[4,15,130,160,193,261],"compare":[5],"the":[6,19,94,109,165,224,235],"effectiveness":[7,196,253],"and":[8,36,44,77,85,88,118,152,172,182,197,203,223,242,254],"safety":[9,163,255],"of":[10,21,40,46,75,79,100,126,135,195,217,227,239,252],"switch":[11],"from":[12,48,263],"reference":[13,70,153,265],"biologics":[14],"their":[16,264],"biosimilars":[17,138,262],"in":[18,31,250],"treatment":[20],"non-infectious":[22],"uveitis":[23],"(NIU).":[24],"Methods:":[25],"A":[26,98],"literature":[27],"search":[28],"was":[29,139,148,229],"conducted":[30,92],"Ovid":[32,34],"MEDLINE,":[33],"EMBASE":[35],"Cochrane":[37],"Central":[38],"Register":[39],"Controlled":[41],"Trials,":[42],"Scopus,":[43],"Web":[45],"Science":[47],"inception":[49],"until":[50],"October":[51],"2024":[52],"(PROSPERO":[53],"protocol":[54],"#:":[55],"CRD42021283386).":[56],"Eligible":[57],"studies":[58,113,209],"involving":[59],"any":[60,67],"age":[61],"groups":[62,155],"with":[63,66,106,259],"NIU":[64,260],"treated":[65],"biosimilar":[68,151],"or":[69],"biologic":[71,154],"were":[72,81,91,114,119,177,200,210],"included.":[73],"Risk":[74],"bias":[76],"certainty":[78,226],"evidence":[80,228,237],"evaluated":[82],"using":[83,93],"ROBINS-I":[84],"GRADE,":[86],"respectively,":[87],"random-effects":[89],"meta-analyses":[90],"Mantel-Haenszel":[95],"method.":[96],"Results:":[97],"total":[99],"11":[101],"studies,":[102],"including":[103],"343":[104],"patients":[105,258],"NIU,":[107],"met":[108],"inclusion":[110],"criteria.":[111],"Most":[112,207],"retrospective":[115],"before-and-after":[116],"designs":[117],"assessed":[120,211],"as":[121,212,231],"having":[122,213],"a":[123,214,247],"serious":[124],"risk":[125,134,166,187,216],"bias,":[127,218],"largely":[128,219],"due":[129,192],"confounding.":[131],"The":[132,186],"relative":[133],"recurrence":[136],"for":[137,168,189,246],"0.98":[140],"(95%":[141],"CI:":[142],"0.55-1.72);":[143],"final":[144],"logMAR":[145],"visual":[146],"acuity":[147],"comparable":[149],"between":[150],"(mean":[156],"difference,":[157],"-0.0116;":[158],"-0.0983":[159],"0.0751).":[161],"For":[162],"outcomes,":[164],"ratios":[167,188],"ophthalmic,":[169],"minor":[170],"systemic,":[171],"major":[173],"systemic":[174],"adverse":[175,198],"events":[176,199],"1.02":[178],"(0.30-3.45),":[179],"1.24":[180],"(0.72-2.14),":[181],"1.99":[183],"(0.67-5.87),":[184],"respectively.":[185,206],"drug":[190],"discontinuation":[191],"lack":[194],"2.44":[201],"(0.80-7.45)":[202],"1.56":[204],"(0.79-8.31),":[205],"included":[208],"\"serious\"":[215],"driven":[220],"by":[221],"confounding,":[222],"overall":[225],"graded":[230],"\"low\".":[232],"Conclusions:":[233],"Currently,":[234],"available":[236],"is":[238],"low":[240],"quality":[241],"demonstrates":[243],"insufficient":[244],"support":[245],"meaningful":[248],"difference":[249],"terms":[251],"when":[256],"switching":[257],"biologics.":[266]},"counts_by_year":[],"updated_date":"2026-11-09T13:22:03.289127","created_date":"2026-11-04T00:00:00"}